These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 6548491
1. DNCB contact sensitization in leprosy: its comparison with other CMI tests. Jayasingh K, Bhatia VN. Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491 [Abstract] [Full Text] [Related]
2. Evaluation of cell mediated immunity in healthy contacts of leprosy. Kurhade AM, Akulwar SL, Pathak AA, Thakar YS, Dhanvijay AG. Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148 [Abstract] [Full Text] [Related]
3. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses. Kundu SK, Hazra SK, Chaudhuri SK, Nandy A. Indian J Lepr; 1985 Jul; 57(1):37-57. PubMed ID: 3839826 [Abstract] [Full Text] [Related]
4. Immunological status of maculoanaesthetic leprosy: leucocyte migration inhibition test as a measure of cell mediated immune response. Rao SS, Rao PR. Lepr India; 1981 Jul; 53(3):340-9. PubMed ID: 7278138 [Abstract] [Full Text] [Related]
5. [Cellular immunity in leprosy patients]. de Arruda MS, de Arruda OS, Fleury RN, Garcia Dde O, Opromolla DV, Ura S. Med Cutan Ibero Lat Am; 1982 Jul; 10(4):231-8. PubMed ID: 6763656 [Abstract] [Full Text] [Related]
6. [Cell mediated immunity in a group of lepers (leukocytes migration inhibition test)]. García González J, Diáz Almeida J, Mayea Milián L, de la Cruz Castillo F. Rev Cubana Med Trop; 1978 Jul; 30(2):53-8. PubMed ID: 368912 [Abstract] [Full Text] [Related]
8. Serum factors affecting the cell migration inhibition response to lepromin. Fliess EL, Ruibal-Ares B, Braun M. Int J Lepr Other Mycobact Dis; 1975 Oct; 43(4):320-6. PubMed ID: 1241688 [Abstract] [Full Text] [Related]
9. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M, Malik A, Abbas SM, Vasenwala S, Kalam A. Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125 [Abstract] [Full Text] [Related]
14. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy. Singh PK, Ratna, Jain PK, Mital VP. Indian J Lepr; 1984 Jan; 56(2):257-63. PubMed ID: 6548495 [Abstract] [Full Text] [Related]
15. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study. Yagnik CS, Jogaikar DG, Mehta JM. Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021 [Abstract] [Full Text] [Related]
16. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants. Malhotra B, Das KD, Tutakne MA, Aggarwal SK. Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784 [Abstract] [Full Text] [Related]
17. [Longitudinal study of a population of leprosy patients by the TML (leukocyte migration test)]. Constant-Desportes M, Puissant A, Saurat JH. Acta Leprol; 1983 Apr; 1(4):211-21. PubMed ID: 6377797 [Abstract] [Full Text] [Related]
18. OKT6+ epidermal Langerhans' cell numbers in DNCB reactions among leprosy patients. Narayanan RB, Girdhar BK, Desikan KV. Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):423-6. PubMed ID: 3755743 [Abstract] [Full Text] [Related]
19. Immunologic responses in patients with lepromatous leprosy. Rea TH, Quismorio FP, Harding B, Nies KM, Di Saia PJ, Levan NE, Friou GJ. Arch Dermatol; 1976 Jun; 112(6):791-800. PubMed ID: 1085131 [Abstract] [Full Text] [Related]
20. Cutaneous responses to antigens and irritants in patients of leprosy. Kumar B, Kaur S, Ganguly NK, Sharma S. Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]